Alyx Arnett

3 weeks ago | sleepreviewmag.com | Alyx Arnett

The use of single-night home sleep testing (HST) to diagnose obstructive sleep apnea (OSA) may have more to do with precedent than with clinical best practice. The longstanding gold standard—in-lab attended polysomnography—is typically conducted over a single night, not because one night provides the full picture, but because the test is too burdensome to repeat, stakeholders say. Even when HST emerged, the devices were complex and needed numerous consumables.

1 month ago | sleepreviewmag.com | Alyx Arnett

For the first time, investigational treatments for narcolepsy type 1 (NT1) are targeting the disorder’s root cause: the loss of orexin-producing neurons. Unlike the symptom-based therapies on the market today, these candidates aim to mimic orexin signaling, offering a potentially disease-modifying approach. Some are also being evaluated for narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH).

Mar 27, 2025 | sleepreviewmag.com | Alyx Arnett

Wearable sleep rings are gaining ground, thanks to their comfort, simplicity, and growing clinical utility. US Food and Drug Administration (FDA)-cleared rings are being used not only for diagnostic sleep testing but also for longitudinal monitoring, while consumer rings drive more attention to sleep health. Companies like SleepImage and Belun Technology market rings cleared for diagnosing obstructive sleep apnea and evaluating sleep stages.

Mar 3, 2025 | sleepreviewmag.com | Alyx Arnett

Treating sleep apnea with a neurostimulator, such as Inspire for obstructive sleep apnea (OSA) or remedē for central sleep apnea (CSA), requires much more than one clinic visit. Steps include identifying a candidate, scheduling and undergoing implantation, activating the device, and titrating it—all before finally having the potential for optimal nightly use. Delays can occur at any stage, prolonging the process and leaving patients untreated.

Feb 26, 2025 | sleepreviewmag.com | Alyx Arnett

Sleep specialists can increase their role in the early detection of cardiac comorbidities in sleep apnea patients. Sleep Review’s Cardiology-Sleep Solutions column shares new technologies that can help. Email [email protected] with solutions you’d like to see featured here. Electrocardiogram (ECG) is a standard channel during in-lab polysomnography (PSG) but is generally absent from home sleep testing (HST) devices.